ABBV-085’s unique mechanism of action relied upon the ability of LRRC15-specific mAb to localize the MMAE payload at high levels in the TME and the cell-permeable properties of MMAE to diffuse into nearby cancer cells and ultimately, induce tumor shrinkage. The gene discussed is LRRC15; the disease is neoplasm.